In this interview we have invited Jack Egelund Madsen, CEO of QNTM Labs ApS. QNTM Labs is a private equity backed, Denmark-based analytical laboratory providing research, development and regulatory compliance services for the Danish and broader European pharmaceutical market.
Jack tells us about his background and the company's ambitious growth plans. Jack also elaborates on the market that QNTM Labs targets and the types of customers the company serves.
Additionally, Jack explains what makes QNTM unique and how it differentiates itself from competitors. Jack also discusses the intention to raise additional capital to support strong growth. Lastly, he shares the company’s biggest goal for 2025, which is to increase revenue fivefold.
FinVoices is powered by Impala Nordic. The host for this episode is Vilhelm Ruhr, Analyst at Impala Nordic.
Disclaimer** Nothing mentioned in the podcast constitutes a buy or sell recommendation. The episode was produced on behalf of the company.
Podden och tillhörande omslagsbild på den här sidan tillhör Impala Nordic. Innehållet i podden är skapat av Impala Nordic och inte av, eller tillsammans med, Poddtoppen.
